These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2013061)

  • 1. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.
    La Du BN; Bartels CF; Nogueira CP; Arpagaus M; Lockridge O
    Cell Mol Neurobiol; 1991 Feb; 11(1):79-89. PubMed ID: 2013061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase.
    Nogueira CP; Bartels CF; McGuire MC; Adkins S; Lubrano T; Rubinstein HM; Lightstone H; Van der Spek AF; Lockridge O; La Du BN
    Am J Hum Genet; 1992 Oct; 51(4):821-8. PubMed ID: 1415224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants.
    Kovarik Z; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2003 Dec; 54(4):239-44. PubMed ID: 14994645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase: phenotyping and genotyping.
    Goodall R;
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):98-110. PubMed ID: 15025799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.
    Bartels CF; Jensen FS; Lockridge O; van der Spek AF; Rubinstein HM; Lubrano T; La Du BN
    Am J Hum Genet; 1992 May; 50(5):1086-103. PubMed ID: 1570838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
    Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
    Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
    Simeon-Rudolf V; Kovarik Z; Skrinjarić-Spoljar M; Evans RT
    Chem Biol Interact; 1999 May; 119-120():159-64. PubMed ID: 10421449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the butyrylcholinesterase H-variant segregating in two Danish families.
    Jensen FS; Bartels CF; La Du BN
    Pharmacogenetics; 1992 Oct; 2(5):234-40. PubMed ID: 1306123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis.
    Jensen FS; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):157-62. PubMed ID: 7793180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase genes in individuals with abnormal inhibition numbers and with trace activity: one common mutation and two novel silent genes.
    Dey DC; Maekawa M; Sudo K; Kanno T
    Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():302-10. PubMed ID: 9547905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants.
    La Du BN; Bartels CF; Nogueira CP; Hajra A; Lightstone H; Van der Spek A; Lockridge O
    Clin Biochem; 1990 Oct; 23(5):423-31. PubMed ID: 2253336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant.
    Masson P; Adkins S; Gouet P; Lockridge O
    J Biol Chem; 1993 Jul; 268(19):14329-41. PubMed ID: 8314794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline.
    Kovarik Z; Simeon-Rudolf V
    J Enzyme Inhib Med Chem; 2004 Apr; 19(2):113-7. PubMed ID: 15449725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
    Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
    Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human plasma cholinesterase variants using molecular biological techniques.
    Jensen FS; Schwartz M; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):142-9. PubMed ID: 7793178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an unstable variant (BChE115D) of human butyrylcholinesterase.
    Primo-Parmo SL; Lightstone H; La Du BN
    Pharmacogenetics; 1997 Feb; 7(1):27-34. PubMed ID: 9110359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes.
    Maekawa M; Sudo K; Kanno T; Kotani K; Dey DC; Ishikawa J; Izumi M; Etoh K
    Clin Chim Acta; 1995 Feb; 235(1):41-57. PubMed ID: 7634491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrylcholinesterase variants and the new methods of molecular biology.
    La Du BN
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):139-41. PubMed ID: 7793177
    [No Abstract]   [Full Text] [Related]  

  • 19. [Frequency of locus E1 variants of plasma butyrylcholinesterase in a French population].
    Masson P; Germani F; Plasse M
    C R Seances Acad Sci D; 1979 Oct; 289(6):537-9. PubMed ID: 118816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in the BCHE gene in patients with no butyrylcholinesterase activity.
    On-Kei Chan A; Lam CW; Tong SF; Man Tung C; Yung K; Chan YW; Au KM; Yuen YP; Hung CT; Ng KP; Shek CC
    Clin Chim Acta; 2005 Jan; 351(1-2):155-9. PubMed ID: 15563885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.